From 16f69d7ebe15d7e4c08b0130a6f52201adf5e847 Mon Sep 17 00:00:00 2001 From: borja Date: Thu, 5 Dec 2024 15:38:41 +0100 Subject: [PATCH] Auto saved by Logseq --- journals/2024_12_05.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/journals/2024_12_05.md b/journals/2024_12_05.md index da730c36..dd72650a 100644 --- a/journals/2024_12_05.md +++ b/journals/2024_12_05.md @@ -56,7 +56,7 @@ - CV: Interim report, add it to the word document - AL: Protocol 2.0 we received full approval from ERC and FDA. Kenya we have IRB, waiting for PPB. We have made some ammendments to the protocol. They have to be submitted to the countries. 3.0 pending submission. 4.0 it changes one of the inclusion criteria. Se sube a 110cm para que sean 15kg. Setup and preparation at sponsor and site levels is continuing. Liconsa will work on the export permit. The product has been manufactured and that allows the import permit in Ghana and wait for PPB for import in Kenya. - AK: Fernando aguirre said in an ideal situation we start on march. best case scenario. but the bulk of the recruitment seems to be happening in May. this is to justify we'll be in june 2026 will still have followup visits and then the db and queries and layers of review and clearing the data. Both countries seem to be aligning to a similar timeline. There are several items, but May june next year will be the most critical months for the trial. - - + - SD: well be sampling people in may-june? Probably perfectly good news. After a productive site visit and finalize what we need in terms of samples. we have everything ready. My samples team hasn't had a lot of luck. But contact - ### Decisiones - TODO Añadir el interim report al documento de Word STOP2030 SCHEDULED: <2024-12-09 Mon>